BET Bromodomain Inhibitors in Triple-Negative Breast Cancer

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：343 / 343
页数：1
相关论文
共 50 条
  • [31] Triple-Negative Breast Cancer: Not Entirely Negative
    Leone, Jose Pablo
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 856 - +
  • [32] New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
    Han, Ye
    Yu, Xiaopeng
    Li, Shuqiang
    Tian, Ye
    Liu, Caigang
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [33] Elucidating the Role of TEAD Inhibitors in Triple-Negative Breast Cancer Treatment
    Battina, Rohith
    Sharif, Ghada
    Moussa, Maha
    Schmidt, Marcel
    Wellstein, Anton
    Riegel, Anna
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 389 (03): : 444 - 444
  • [34] Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer
    Peter Larsson
    Daniella Pettersson
    Maxim Olsson
    Sithumini Sarathchandra
    Alexandra Abramsson
    Henrik Zetterberg
    Ella Ittner
    Eva Forssell-Aronsson
    Anikó Kovács
    Per Karlsson
    Khalil Helou
    Toshima Z. Parris
    Cell Death Discovery, 10
  • [35] Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer
    Larsson, Peter
    Pettersson, Daniella
    Olsson, Maxim
    Sarathchandra, Sithumini
    Abramsson, Alexandra
    Zetterberg, Henrik
    Ittner, Ella
    Forssell-Aronsson, Eva
    Kovacs, Aniko
    Karlsson, Per
    Helou, Khalil
    Parris, Toshima Z.
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [36] Nitric Oxide Inhibitors Hit Target for Triple-Negative Breast Cancer
    Firger, Jessica
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (08):
  • [37] Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer
    Larsson, Peter
    Pettersson, Daniella
    Olsson, Maxim
    Forssell-Aronsson, Eva
    Kovacs, Aniko
    Karlsson, Per
    Helou, Khalil
    Parris, Toshima Z.
    CANCER RESEARCH, 2023, 83 (05)
  • [38] Therapeutic targeting of bromodomain and extra-terminal proteins degradation in triple-negative breast cancer
    Bai, Longchuan
    Zhou, Bing
    Yang, Chao-Yie
    Ji, Jiao
    McEachern, Donna
    Przybranowski, Sally
    Wang, Shaomeng
    CANCER RESEARCH, 2017, 77
  • [39] MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer Models
    Smith, John C.
    Husted, Stefan
    Pilrose, Jay
    Ems-McClung, Stephanie C.
    Stout, Jane R.
    Carpenter, Richard L.
    Walczak, Claire E.
    CANCERS, 2023, 15 (13)
  • [40] LAPATINIB SENSITIZES TRIPLE-NEGATIVE BREAST CANCER CELLS TO HDAC INHIBITORS
    Chen, Y-J.
    Chien, P-H.
    Huang, W-C.
    ANNALS OF ONCOLOGY, 2012, 23 : 34 - 34
12345